View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

ProAct IT Group AB: 1 director

A director at ProAct IT Group AB bought 162,666 shares at 115.000SEK and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

 PRESS RELEASE

Sysco Celebrates Arrival of Heavy-Duty Electric Vehicles in Its Headqu...

Sysco Celebrates Arrival of Heavy-Duty Electric Vehicles in Its Headquarters City of Houston, TX, Growth of Electric Fleet Globally HOUSTON, May 14, 2024 (GLOBE NEWSWIRE) -- Sysco is hosting a news conference to celebrate the arrival of new heavy duty electric vehicles to the company’s hometown Houston distribution facility, the first for Sysco in Texas. The company will also announce its progress in deploying EVs across the United States and globally. Sysco’s Chief Administrative Officer, Neil Russell, will provide formal remarks and members of the media will have the opportunity to ask...

Boston Omaha Corp : 1 director

A director at Boston Omaha Corp sold 789,774 shares at 15.630USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

 PRESS RELEASE

Bitcoin Depot Reports First Quarter 2024 Financial Results

Bitcoin Depot Reports First Quarter 2024 Financial Results Strengthens Footprint with Over 2,000 New Retail Locations Signed in the First Quarter of 2024 Committed to Acquire Approximately 3,200 Additional Kiosks Year-to-Date to Support Expansion Strategy Remains on Track to Deploy 8,000 Kiosks by the End of 2024 ATLANTA, May 14, 2024 (GLOBE NEWSWIRE) -- Bitcoin Depot Inc. (“Bitcoin Depot” or the “Company”), a U.S.-based Bitcoin ATM operator and leading fintech company, today reported financial results for the first quarter ended March 31, 2024. Bitcoin Depot will host a conference cal...

 PRESS RELEASE

Palisade Bio Reports First Quarter 2024 Financial Results and Provides...

Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update – Company on track to commence Phase 1 human clinical study of lead product candidate, PALI-2108, for the treatment of Ulcerative Colitis (UC) before year end – Sufficient cash on hand to execute on business plan and reach clinical and regulatory milestones into 2025 Carlsbad, CA, May 14, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with ...

 PRESS RELEASE

Jasper Therapeutics Reports First Quarter 2024 Financial Results and R...

Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments REDWOOD CITY, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU), today announced results for the fiscal quarter ended March 31, 2024, and reported recent corporate developments. “We have continued to make ...

 PRESS RELEASE

Franklin Electric Appoints Joe Ruzynski as CEO; Gregg Sengstack Remain...

Franklin Electric Appoints Joe Ruzynski as CEO; Gregg Sengstack Remains Executive Chairperson FORT WAYNE, Ind., May 14, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: FELE), a global leader in water and energy systems, announced today that its Board of Directors has appointed Joe Ruzynski as Chief Executive Officer and a member of the Board, effective July 1, 2024. Gregg Sengstack, who has served as CEO since 2014 and Chairperson since 2015, will continue as Executive Chairperson. Ruzynski, 49, joins Franklin Electric from nVent Electric plc (NYSE: NVT), a global leader in electrical connection and ...

 PRESS RELEASE

Ocugen Provides Business Update with First Quarter 2024 Financial Resu...

Ocugen Provides Business Update with First Quarter 2024 Financial Results Conference Call and Webcast Today at 8:30 a.m. ET All three first-in-class modifier gene therapy product candidates currently in the clinic with OCU400 Phase 3 in progressOCU400 on track to meet 2026 Biologics License Application (BLA) and Market Authorization Application (MAA) approval targets MALVERN, Pa., May 14, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, a...

 PRESS RELEASE

Middlefield Banc Corp. Announces 2024 Second-Quarter Cash Dividend Pay...

Middlefield Banc Corp. Announces 2024 Second-Quarter Cash Dividend Payment MIDDLEFIELD, Ohio, May 14, 2024 (GLOBE NEWSWIRE) -- Middlefield Banc Corp. (NASDAQ: MBCN) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per common share. The second-quarter dividend is payable on June 14, 2024, to shareholders of record on May 31, 2024. About Middlefield Banc Corp. Middlefield Banc Corp., headquartered in Middlefield, Ohio, is the Bank holding Company of The Middlefield Banking Company, with total assets of $1.82 billion at March 31, 2024. The Bank operate...

Haitian International Holdings: 1 director

A director at Haitian International Holdings sold 834,000 shares at 28.223HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...

Beijing Enterprises Water Group Ltd: 1 director

A director at Beijing Enterprises Water Group Ltd sold 2,000,000 shares at 2.230HKD and the significance rating of the trade was 90/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...

Guangdong Wanlima Industry Co Ltd: 1 director

A director at Guangdong Wanlima Industry Co Ltd maiden bought 75,500 shares at 3.970CNY and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...

ABGSC Construct. & Real Estate Research ... (+2)
  • ABGSC Construct. & Real Estate Research
  • Peter Sehested
 PRESS RELEASE

aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in P...

aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis Independent data and safety monitoring board (DSMB) recommends continuation of study without any modifications. Findings further support favorable safety profile of efzofitimod. SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that an inde...

 PRESS RELEASE

Reviva Reports First Quarter 2024 Financial Results and Recent Busines...

Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights – Gained alignment with U.S. Food and Drug Administration (FDA) on brilaroxazine clinical trials for New Drug Application (NDA) submission in schizophrenia – – Registrational RECOVER-2 trial expected to initiate Q2 2024; topline data expected Q3 2025 – – Topline data from 1-year open-label extension (OLE) trial expected Q4 2024 – CUPERTINO, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company ...

 PRESS RELEASE

Provectus Biopharmaceuticals Announces Eight Presentations of Rose Ben...

Provectus Biopharmaceuticals Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2024 Annual Meeting PDAT clinical outcomes for infectious keratitis from Brazil and Mexico KNOXVILLE, TN, May 14, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that clinical and non-clinical data on rose bengal photodynamic antimicrobial therapy (“RB PDAT”) were presented at the annual meeting of the Association for Research in Vision and Ophthalmology (“ARVO”), held May 5-9, 2024 in Seattle, Wash...

 PRESS RELEASE

Clene to Present at Upcoming May Conferences

Clene to Present at Upcoming May Conferences SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis and multiple sclerosis, today announced that it will participate in the following investor conferences in May. Mizuho Neuroscience Summit 2024Dates: May 20-21, 2024Location: ...

 PRESS RELEASE

Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg ...

Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules The Company has also completed the GMP validation work allowing for the release of both MDMA dosage formats VANCOUVER, British Columbia, May 14, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada-licensed GMP psychedelics pharmaceutical manufacturer specializing in controlled substances such as botanical psilocybin and MDMA, is pleased to announce it has received a Certificate of Analysis (COA) from independent third-party laboratory testing, confir...

 PRESS RELEASE

BranchOut Food Secures Large Scale Production Facility in Peru Capable...

BranchOut Food Secures Large Scale Production Facility in Peru Capable of $40M in Production Capacity; Estimated 40-50% Gross Margins Build out to begin immediately, with production expected to commence in the third quarter LIMA, Peru, May 14, 2024 (GLOBE NEWSWIRE) -- BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that it has signed a long term lease for a 50,000 square foot production facility in Peru. Under the terms of the agreement, BranchOut Food has the first right to purchase t...

 PRESS RELEASE

Peter S. Lynch 2024 Recipient of Graham & Dodd, Murray, Greenwald Priz...

GREENWICH, Conn.--(BUSINESS WIRE)-- Gabelli Funds announces Peter S. Lynch as the 2024 recipient of the Graham & Dodd, Murray, Greenwald Prize for Value Investing. He was presented with the Prize at the firm’s thirty-ninth client conference on Friday, May 10th in New York. In announcing Peter S. Lynch as the 2024 recipient, Tano Santos, the Robert Heilbrunn Professor of Asset Management and Finance and Academic Director of the Heilbrunn Center for Graham & Dodd Investing at Columbia Business School stated, “Given his accomplishments, Peter has made a lasting and important impact on the field...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch